Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Region-specific Adipose Tissues and Liver Changes Associated With Semaglutide Treatment in Chronic Kidney Disease Patients

NCT07187830 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT07187830
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07187830 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Region-specific Adipose Tissues and Liver Changes Associated With Semaglutide Treatment in Chronic Kidney Disease Patients
Lead sponsor
University of Alberta
Phase
Observational
Overall status
Recruiting
Start date
February 23, 2026
Completion date
January 15, 2028
Enrollment
52 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease in type 2 diabetes, obesity & overweight